cAMP signaling in cancer: a PKA-CREB and EPAC-centric approach

MB Ahmed, AAA Alghamdi, SU Islam, JS Lee, YS Lee - Cells, 2022 - mdpi.com
Cancer is one of the most common causes of death globally. Despite extensive research
and considerable advances in cancer therapy, the fundamentals of the disease remain …

Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development

WG Robichaux III, X Cheng - Physiological reviews, 2018 - journals.physiology.org
This review focuses on one family of the known cAMP receptors, the exchange proteins
directly activated by cAMP (EPACs), also known as the cAMP-regulated guanine nucleotide …

Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions

M Schmidt, FJ Dekker, H Maarsingh, MC Michel - Pharmacological reviews, 2013 - Elsevier
Since the discovery nearly 60 years ago, cAMP is envisioned as one of the most universal
and versatile second messengers. The tremendous feature of cAMP to tightly control highly …

Sulfonylureas: a new look at old therapy

PM Thulé, G Umpierrez - Current diabetes reports, 2014 - Springer
Sulfonylurea compounds were the first available oral antidiabetic agents and they remain an
important tool in our quest for optimal glucose control. The sulfonylureas stimulate the …

Cyclic AMP dynamics in the pancreatic β-cell

A Tengholm - Upsala journal of medical sciences, 2012 - Taylor & Francis
Insulin secretion from pancreatic β-cells is tightly regulated by glucose and other nutrients,
hormones, and neural factors. The exocytosis of insulin granules is triggered by an elevation …

Isoform-specific antagonists of exchange proteins directly activated by cAMP

T Tsalkova, FC Mei, S Li… - Proceedings of the …, 2012 - National Acad Sciences
The major physiological effects of cAMP in mammalian cells are transduced by two
ubiquitously expressed intracellular cAMP receptors, protein kinase A (PKA) and exchange …

Optical control of insulin release using a photoswitchable sulfonylurea

J Broichhagen, M Schönberger, SC Cork… - Nature …, 2014 - nature.com
Sulfonylureas are widely prescribed for the treatment of type 2 diabetes mellitus (T2DM).
Through their actions on ATP-sensitive potassium (KATP) channels, sulfonylureas boost …

Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPARγ and SUR agonists

MK Ibrahim, IH Eissa, MS Alesawy, AM Metwaly… - Bioorganic & medicinal …, 2017 - Elsevier
Peroxisome proliferator-activated receptor gamma (PPARγ) and sulfonylurea receptor
(SUR) play crucial roles in management of type-2 diabetes mellitus. In this study, a series of …

Design, molecular docking, synthesis, anticancer and anti-hyperglycemic assessments of thiazolidine-2, 4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR …

MA Abdelgawad, K El-Adl, SSA El-Hddad, MM Elhady… - Pharmaceuticals, 2022 - mdpi.com
Newly designed thiazolidine-2, 4-diones 3–7a–c were synthesized, and their anticancer
activities were screened against three cancer lines. They showed potent activities against …

Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists

MK Ibrahim, IH Eissa, AE Abdallah, AM Metwaly… - Bioorganic & medicinal …, 2017 - Elsevier
In our effort to develop potent anti-hyperglycemic agents with potential agonistic activities
toward PPARγ and SUR, three novel series of quinoxaline derivatives bearing sulfonylurea …